A Pusan National University study has identified a signalling pathway [...]

Kupando has dosed the first patient in a Phase 1 [...]

Vaximm AG has completed analysis of two clinical studies evaluating [...]

Enterome Phase 1/2 data show EO2463-induced CD8 T-cell expansion was [...]

Poolbeg Pharma has dosed the first patient in a clinical [...]

Poolbeg Pharma has received a decision to grant a European [...]

Poolbeg Pharma has presented two posters at the European Hematology [...]

Poolbeg Pharma has activated the first clinical site and begun [...]

IMU Biosciences has extended its Series A financing to more [...]

Regeneron Pharmaceuticals has entered the radiopharmaceuticals field through a multi-programme [...]